1 – 10 of 27
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Conversion between NMSS and MDS-NMS in Parkinson's Disease
- Contribution to journal › Article
-
Mark
Chapter 34 - Dopamine replacement for Parkinson's disease: Clinical approaches and experimental underpinnings
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Chapter 12 - Molecular mechanisms of l-DOPA-induced dyskinesia
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Screening Tool Improves Recognition of Movement Disorders by Internists and Paediatricians in Patients With Inherited Metabolic Diseases
- Contribution to journal › Article
- 2024
-
Mark
Structural-functional properties of direct-pathway striatal neurons at early and chronic stages of dopamine denervation
- Contribution to journal › Article
-
Mark
The clinical spectrum of ataxia telangiectasia in a cohort in Sweden
- Contribution to journal › Article
- 2023
-
Mark
DOPA decarboxylase is an emerging biomarker for Parkinsonian disorders including preclinical Lewy body disease
- Contribution to journal › Article
-
Mark
Comparison of dyskinesia profiles after L-DOPA dose challenges with or without dopamine agonist coadministration
- Contribution to journal › Article
-
Mark
Comorbidities and clinical outcomes in adult- and juvenile-onset Huntington’s disease : a study of linked Swedish National Registries (2002–2019)
- Contribution to journal › Article
-
Mark
A Paradigm Shift in the Management of Patients with Parkinson's Disease
- Contribution to journal › Scientific review
